$553 Million is the total value of Bellevue Group AG's 121 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TTPH | Exit | Tetraphase Pharmaceuticals, Inc. | $0 | – | -22,000 | -100.0% | -0.02% | – |
| ZFGN | Exit | Zafgen, Inc. | $0 | – | -20,000 | -100.0% | -0.02% | – |
| INFI | Exit | Infinity Pharmaceuticals, Inc. | $0 | – | -160,000 | -100.0% | -0.04% | – |
| HTWR | Exit | Heartware International, Inc. | $0 | – | -3,813 | -100.0% | -0.04% | – |
| THC | Exit | Tenet Healthcare Corporation | $0 | – | -10,000 | -100.0% | -0.05% | – |
| CYH | Exit | Community Health Systems, Inc. | $0 | – | -50,000 | -100.0% | -0.11% | – |
| CPHD | Exit | Cepheid Inc. | $0 | – | -30,000 | -100.0% | -0.17% | – |
| SUPN | Exit | Supernus Pharmaceuticals, Inc. | $0 | – | -164,000 | -100.0% | -0.63% | – |
| STJ | Exit | St. Jude Medical, Inc. | $0 | – | -60,000 | -100.0% | -0.88% | – |
| MDVN | Exit | Medivation, Inc. | $0 | – | -78,000 | -100.0% | -0.88% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bellevue Asset Management AG #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.